APAC CRO MARKET
Get instant access to latest e-book

latest newsRead more...

20

Feb 2019

Aucta Pharmaceuticals and Oakrum Pharma Announce Product Development and Commercial Cooperation

Aucta Pharmaceuticals Inc Aucta announced today that it has entered into an agreement with Oakrum Pharma LLC Oakrum to develop and produce four A prescription generic product intended to be commercialized in the United States under the Oakrum trademark These products are expected to serve…

20

Feb 2019

Exicure Announces License and Development Agreement with Dermelix Biotherapeutics in Rare Genetic Skin Diseases

Exicure Inc OTCQB XCUR the pioneer in gene regulatory and immunotherapeutic drugs utilizing spherical nucleic acid SNA constructs and Dermelix Biotherapeutics a biopharmaceutical company focused on the development of innovative treatments for rare genetic skin diseases today announced a license and development agreement to advance…

19

Feb 2019

QIAGEN partners with Ares Genetics to advance global fight against antibiotic-resistant pathogens

QIAGEN NV today announced a broad agreement with Ares Genetics a subsidiary of Curetis NV to develop innovative bioinformatics and assay solutions to accelerate research targeting the growing global health challenges posed by antibioticresistant bacteria QIAGEN has acquired an exclusive license to leverage Ares Genetics…

19

Feb 2019

WuXi STA and BioLingus sign exclusive technology and marketing collaboration for sublingual delivery

STA Pharmaceutical Co Ltd WuXi STA a subsidiary of WuXi AppTec and BioLingus a Swiss biotech company announce they have formed an exclusive technology and marketing collaboration for sublingual delivery Under the terms of the collaboration WuXi STA will have exclusive access to BioLingus technology…

press releasesRead more...

20

Feb 2019

ARS Pharmaceuticals Announces FDA Fast Track Designation for ARS-1 Intranasal Epinephrine Spray

ARS Pharmaceuticals Inc a pharmaceutical company dedicated to empowering atrisk patients and caregivers to better protect themselves from severe allergic reactions potentially leading to anaphylaxis today announced that the US…

20

Feb 2019

Gamida Cell Announces Agreement with Editas Medicine to Evaluate Use of CRISPR Genome Editing Technology in NAM-NK Cells

Gamida Cell Ltd a leading cellular and immune therapeutics company today announced an agreement with Editas Medicine Inc a leading genome editing company to evaluate the potential use of Editas…

20

Feb 2019

AlzProtect, on Track for a Phase 2 Entry in 2019, for its Drug Candidate AZP2006

AlzProtect a biopharmaceutical company engaged in the development of drugs for the treatment of Alzheimers disease and Progressive Supranuclear Palsy PSP announced today the successful completion of the latest phase…

20

Feb 2019

Calypso Biotech BV Secures 20 Million EUR in Series A Financing and Strengthens Team to Develop Anti-IL-15 Therapeutic Antibody for Autoimmune Diseases

Calypso Biotech an emerging leader in the development of therapeutic antibodies for autoimmune diseases announces today the closing of a M Series A financing coled by Gilde Healthcare and Inkef…

EventsRead more...

20-21

Feb 2019

10th Annual RNA Therapeutics Conference

SMI GROUP
Copthorne Tara Hotel

20-21

Feb 2019

World Congress on Drug Discovery and Drug Design

Conference Series LLC Ltd
Holiday Inn Singapore Atrium

20-21

Feb 2019

3D Cell Culture 2019

SMi Group
Copthorne Tara Hotel London Kensington

20-21

Feb 2019

10th Annual RNA Therapeutics

SMi Group
Copthorne Tara Hotel London Kensington

TOP ARTICLES

  • 4

    Are you Ready for EU FMD?

    With the deadline looming for enactment of EU FMD and US DSCSA Vikash Pushpraj Senior Vice President rfxcel explains how achieving compliance is about much more..
  • 6

    Cancer Stem Cell (CSC) Inhibitors

    Cancer as a group of heterogeneous diseases very well known Unimaginable amounts of money and manhours have been spent in finding cure for this deadly disease H..

Knowledge Bank

  • Interviews

    Merck

    Staff Engineer, Manufacturing Science and Technology, South East Asia
    Karen Chan is a process engineer at Merck Pte Ltd Chan has six years of experience in the biopharmaceutical industry and two years of experience in research development She provides technical support in areas such as process development troubleshoot..

Editorial Section

  • Strategy

    WAYS TO CREATE MORE AND MORE CONSISTENT PERFORMERS

    For all pharma businesses it is a challenge to enable their field forceSales and Marketingto be consistent performers The success or failure in this direction will accordingly decide the fate of the organisations Even if an organisation has highly innovative…

  • Research development

    New and Novel Drug Delivery Technologies

    By infusing drugs with new and innovative therapeutic benefits drug delivery systems extend products profitable lifecycle giving pharmaceutical companies competitive and financial advantages and providing patients with improved medications Formulation development is being used in the creation of new dosage…

  • Clinical Trials

    ELIXIR FOR SOURCING AND RETAINING CANDIDATES

    Many pharma companies have been suffering silently from shortage of suitable candidates to fill up vacancies in the field and also of high attrition rate leading to terrible but avoidable loss of business due to vacancies In this article lets…

TOP